A combination of thyme and ivy exerts potent anti-inflammatory and mucus-normalizing activity in vivo and inhibits 5-LO and PDE4 Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014
Cough suppresive and bronchodilatory activities of polysaccharides isolated from the malian medicinal plants Source: Annual Congress 2009 - Treatment of airways disease Year: 2009
The electrophilic 17-oxo-docosahexaenoic acid (17-oxo-DHA) enhances the anti-inflammatory potency of fluticasone propionate Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease Year: 2015
Potential effect of the extract of zataria multiflora and its consituent carvacrol on lung inflammation of sensitized guinea pigs Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine Year: 2013
Antitussive activity of the herbal polysaccharides on mechanically induced cough in cats Source: Eur Respir J 2006; 28: Suppl. 50, 438s Year: 2006
In-vitro bronchodilator activity clitoria ternatea and A. precatorius Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013
The anti-inflammatory effects of eucalyptol in a mouse model of LPS-induced pulmonary inflammation are mediated by TRPM8 Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models Year: 2016
Decoy chemokine neutraligands with anti-asthmatic activity Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015
Anti-inflammatory effects of the novel PDE4 inhibitor CHF6001 on virus inducible cytokines Source: International Congress 2014 – Allergy and asthma: novel findings based on human cell biology Year: 2014
Mucus-normalizing activity of a fixed thyme and primula extract combination: Reduction of LPS-induced goblet cell metaplasia and mucin production in vivo Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015
Polyphenolic compounds and experimentally induced allergic asthma Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013
Anti-inflammatory effects of formoterol and fluticasone propionate in bronchial epithelial cells Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease Year: 2015
Anti-inflammatory, antioxidant and immunomodulatory effects of curcumin in sensitized rat Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology Year: 2017
Evaluation of bronchodilator activity of A. precatorius leaves Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013
LATE-BREAKING ABSTRACT: GW870086: A potent anti-inflammatory glucocorticoid with a novel pharmacological profile Source: Annual Congress 2013 –Hot topics on airway diseases: new horizons in treatment Year: 2013
Ovalbumin-induced asthma model in Brown Norway rats demonstrates potential anti-asthmatic effects of Neu-164, a novel antioxidant and anti-inflammatory compound Source: Annual Congress 2008 - Understanding allergic airway inflammation with the help of animal models Year: 2008
A fixed combination of thyme and primula dry extracts normalizes goblet cell hyperplasia and MUC5AC formation in vivo and in vitro Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016
Pharmacological profile of a novel, potent and oral TRPA1 antagonist. Characterization in a preclinical model of induced cough Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015
Antioxidant activity of anticholinergic bronchodilatators Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II Year: 2008
In vitro profile of the new inhaled pan-JAK inhibitor LAS194046Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014